B
JNCE
Bailard’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-90,200
| Closed | -$167K | – | 808 |
|
|
2023
Q1 | $167K | Buy |
+90,200
| New | +$167K | 0.01% | 670 |
|
|
2022
Q1 | – | Sell |
-31,952
| Closed | -$267K | – | 827 |
|
|
2021
Q4 | $267K | Hold |
31,952
| – | – | 0.01% | 572 |
|
|
2021
Q3 | $237K | Hold |
31,952
| – | – | 0.01% | 623 |
|
|
2021
Q2 | $217K | Buy |
31,952
+15,400
| +93% | +$105K | 0.01% | 652 |
|
|
2021
Q1 | $170K | Buy |
16,552
+1,000
| +6% | +$10.3K | 0.01% | 674 |
|
|
2020
Q4 | $109K | Buy |
15,552
+900
| +6% | +$6.31K | 0.01% | 615 |
|
|
2020
Q3 | $120K | Hold |
14,652
| – | – | 0.01% | 528 |
|
|
2020
Q2 | $101K | Hold |
14,652
| – | – | 0.01% | 487 |
|
|
2020
Q1 | $70K | Hold |
14,652
| – | – | 0.01% | 442 |
|
|
2019
Q4 | $128K | Sell |
14,652
-8,148
| -36% | -$71.2K | 0.01% | 521 |
|
|
2019
Q3 | $76K | Hold |
22,800
| – | – | ﹤0.01% | 522 |
|
|
2019
Q2 | $113K | Buy |
22,800
+8,000
| +54% | +$39.6K | 0.01% | 527 |
|
|
2019
Q1 | $92K | Buy |
+14,800
| New | +$92K | 0.01% | 531 |
|